Prof. Dr. Raymond Miralbell
Address: Carrer de Vilana, 12, 08022 Barcelona, Barcelona, Catalunya, Spain
Gender: Male
About the Doctor / Professional
Professor Dr. Raimon Miralbell is the Director of the Radiotherapy Oncology Service of the Teknon Oncology Institute, Chief of the Radio-oncology Services for the University Hospitals of Geneva in Switzerland and Professor at the Faculty of Medicine of the University of Geneva.
He has a Medical Doctor’s degree from the University of Geneva. Since 1997 he has studied at renowned European and North American Centers, of which worth mentioning is the Royal Marsden Hospital in Sutton-Surrey in the United Kingdom and the City of Hope National Medical Centre in Duarte, California, in the United States. A Doctor and researcher for the proton therapy project from 1987 to 1989 at the Massachusetts General Hospital and for the Harvard Cyclotron Laboratory at Harvard University, Cambridge in Boston, Massachusetts, his main research areas are prostate cancer, breast cancer, high precision radiotherapy techniques and radio-biological mathematical models on the response of cancer to radiation. He is a member and founder of the European Scientific Institute (ESI) tied to the Centre Européen de Recherche Nucléarie, CERN (European Organization for cancer research and treatment) where he develops and manages training programs and new radiotherapy technology research projects and he has been the President of the Swiss Proton Users Group. He has also been invited as a speaker at numerous national and international meetings.
His main expertise and research domains in the field of radiation oncology are:
- Imaging for radiotherapy treatment planning of breast and prostate cancer
- Treatment precision optimization through image guided radiotherapy
- Biomathematical modeling of prostate cancer response to irradiation and fractionation sensitivity: ultra-hypofractionation as a dose escalation method.
- Biomathematical modeling for salvage radiotherapy after post-irradiation local failure for prostate cancer
- Stereotactic beam radiotherapy for prostate, gynecologic, ocular/orbital, and oligometastatic tumors
- Proton therapy
Degree: University of Geneva, 1997
Residency: Radiation Oncology at the University Hospital of Sant Pau, Barcelona (1979- 1984)
- 2018 (and present position) - Medical Director of the Centro de Protonterapia Quironsalud, Pozuelo de Alarcón, Madrid, Spain
- Since 2007 - Professor at the University of Geneva Medical School
- 2006 through August 2019 (retirement) - Chairman of the radiation oncology department, HUG, Geneva, Switzerland
- 2000-2008 - Chairman of the Swiss Proton Users Group.
- Since 1999 - Chairman of the of the radiation oncology department, Institut Oncològic Teknon, Barcelona, Spain
- Since 1992 - Contributor for the European Scientific Institute (ESI) attached to the Centre Européen de Recherche Nucléaire (CERN) in several training and research projects in the field of new technologies in Radiation Therapy
- 1991-2006 - Full-time staff radiation oncologist at the radiation oncology department, Hôpitaux Universitaires de Genève (HUG), Geneva, Switzerland.
- 1990-1991 - Full-time staff radiation oncologist at the Radiation Oncology at the University Hospital of Sant Pau, Barcelona.
- 1987-1989 - Senior resident first, and clinical and research fellow later, at the Radiation Medicine Department, Harvard Cyclotron, and Edwin Steele Laboratory, Massachusetts General Hospital, Harvard University, Boston and Cambridge, Massachusetts, US.
- 2019 - Cofounder of start-up, TERAPET SA, a CERN spin-off aiming to develop advanced technology in the treatment of cancer with proton beams.
- Imaging for radiotherapy treatment planning
- Treatment precision optimization through image guided radiotherapy
- Tracing of the biochemical relapse after curative surgery or radiotherapy
- Prognostic value of hypoxic markers (pathological and imaging)
- Quality of life studies in fragile patients on androgen deprivation
- Biological modeling for salvage radiotherapy after post-irradiation local failure
- Fractionation sensitivity with high-dose fractions
- Epidemiology of locally advanced prostate cancer and treatment in the elderly
- Biological and mechanical synergies to deal with proton therapy pitfalls: Minibeams, FLASH, arcs, and gantryless rooms.
- Is prone free-breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A dosimetric analysis.
- Single-fraction prostate stereotactic body radiotherapy: dose reconstruction with electromagnetic motion tracking.
- Dose-escalated volumetric modulated arc therapy for total marrow irradiation: A feasibility dosimetric study with 4DCT planning and simultaneous integrated boost.
- Urethra-sparing stereotactic body radiation therapy for prostate cancer: quality assurance of a randomized phase 2 trial.
- Atlas sampling for prone breast automatic segmentation of organs at risk: the importance of patients’ body mass index and breast cup size for an optimized contouring of the heart and the coronary vessels.
- Electromagnetic transponder localization and real-time tracking for prostate cancer radiation therapy: clinical impact of metallic hip prostheses.
- Resources-stratified guidelines for classical Hodgkin Lymphoma
- Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.
- FLASH and mini beams in radiation therapy: the effect of microstructures on time and space and their potential application to protontherapy.
- Prostate cancer non-ascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: 3 case reports and review of the literature.
- Image-guided total-body irradiation with a movable electronic portal imaging device for bone marrow transplant conditioning.
- Clinical experience with lung-specific electromagnetic transponders for real-time tumor tracking in lung stereotactic body radiotherapy.
- Stereotactic beam radiotherapy for prostate cancer: is less, more?
- Mild hyperthermia by MR-guided focused ultrasound in an ex-vivo model of osteolytic bone tumor: optimization of the spatio-temporal control of the delivered temperature.
- Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE-SHOT trial.
- Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome end Toxicity of SBRT and Elective Nodal Radiotherapy.
- Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.
- Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT.
- From bunker construction to patient treatment: quality controls applied to modern radiotherapy techniques.
- Neck management in head and neck squamous cell carcinomas: where do we stand?
- Twice- vs. thrice-weekly moderated hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?
- Oligometastatic prostate cancer: The game is a foot
- First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9
- Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models
- Improving 3D-printing of megavoltage X-rays radiotherapy bolus with surface-scanner
- Contouring workload in adjuvant breast cancer radiotherapy
- ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.
- Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.
- Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
- Urethra- sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
- The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An 18F-MISO PET-MRI Study.
- Sexual health after radiotherapy
- Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients
- Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation Approach
- Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?
- Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer
- Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule
- The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy
- Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial
- Atlas-guided generation of pseudo-CT images for MRI-only and hybrid PET-MRI-guided radiotherapy treatment planning
- Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance
- Automatic segmentation of breast in prone position: Correlation of similarity indexes and breast pendulousness with dose/volume parameters
- Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences
- Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature
- Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging
- Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis
- Moderate Hypofractionated Protacted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter ?
- Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapy
- Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients
- Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
- PET/MR in Breast Cancer
- Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function In Men Treated with Radiotherapy for Prostate Cancer
- High-dose salvage radiation therapy for prostate cancer after relapse: in regard to d’Angelillo et al.
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20 year follow-up of a randomised phase 3 trial
- Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study
- Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review
- Results of dose-adapted salvage radiotherapy after radical prostatectomy based on an endorectal MRI target definition model
- Editorial comment from Dr Zilli and Dr Miralbell to early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria
- 11C-choline PET-CT in the primary diagnosis of prostate cancer: impact on treatment planning
- Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial
- Interaction of -3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines
- In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidance
- PET-CT imaging and the oligometastatic prostate cancer patient: an opportunity for a curative approach with high-dose radiotherapy?
- Prostate-rectum spacers: optimization of prostate cancer irradiation
- Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome
- Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy
- A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy
- Planning for the future: cancer incidence projections in Switzerland up to 2019
- First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy
- Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis
- Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
- Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases
- Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
- Prostate cancer and androgen deprivation: benefits of psychological counseling
- A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes
- In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy
- Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
- Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study
- Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18F-choline PET/CT
- The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
- Clinical impact of (18)F-choline PET/CT in patients with recurrent prostate cancer
- Long-term post-treatment MR and PET/CT imaging in prostate cancer patients in complete remission after curative radiotherapy with or without androgen deprivation: the image of cure.
- Stereotactic radiotherapy for prostate cancer: treatment approaches and clinical outcomes
- The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the rare cancer network
- Breathing adapted radiotherapy: a 4D gating software for lung cancer
- Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation”
- Low-dose radiotherapy in indolent lymphoma
- Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy” Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9-2.2) Gy
- High-dose brachytherapy boost to the dominant intra-prostatic tumor region: hemi-irradiation of prostate cancer.
- Twice-weekly hypofractionated intensity-modulated radiotherapy for localized” prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study
- Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapy
- Boosting the tumor bed from deep-seated tumors in early-stage breast cancer: a planning study between electron, photon, and proton beams
- Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity
- Incidental detection of synchronous primary tumours during staging workup for prostate cancer
- Unilateral radiotherapy for tonsil cancer: Potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangement
- Hypofractionated Boost to the Dominant Tumor region with Intensity Modulated Stereotactic Radiotherapy for Prostate Cancer: A Sequential Dose Escalation Pilot Study
- Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis
- Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study
- 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer
- RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study
- External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
- Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors
- Total body irradiation: present and future
- Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy
- Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study
- Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study
- Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence
- [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma
- Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients
- Quality of life and social integration after allogeneic hematopoietic SCT
- Increased risk of colon cancer after external radiation therapy for prostate cancer
- Recent trends in prostate cancer mortality show a continuous decrease in several countries
- Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer
- Short and long-term mortality of localized prostate cancer
- Proton beam therapy: clinical indications and summary of the Swiss experience
- Stereotactic radiotherapy for ocular melanoma: initial experience using closed eyes for ocular target immobilization
- Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group
- 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low PSA values (<1ng/ml) after radical prostatectomy
- Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high-risk for local failure
- (11)C-acetate PET in the early evaluation of prostate cancer recurrence
- Quality assurance for radiotherapy in prostate cancer: point dose measurements in intensity modulated fields with large dose gradients
- Guidelines for primary radiotherapy of patients with prostate cancer
- Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group study 9031
- The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: A rare cancer network retrospective study.
- Proton beam radiation therapy versus fractionated stereotactic radiotherapy for uveal melanomas: a comparative study
- Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients
- Fractionated stereotactic radiotherapy boost for gyencologic tumors: an alternative to brachytherapy?
- Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network.
- Spot-scanning proton radiation therapy for recurrent, residual, or untreated intracranial meningiomas: preliminary clinical experience.
- Target repositioning optimization in prostate cancer: is intensity modulation radiotherapy under stereotactic conditions feasible?
- Renal dysfunction in patients with hematologic malignancies undergoing bone marrow transplantation: a prospective assessment
- Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild to moderate late rectal toxicity
- Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy
- Dosimetric implications of changes in repositioning and organ motion in conformal radiotherapy for prostate cancer.
- Potential role of IMRT and protons in the treatment of the breast and regional nodes.
- Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.
- Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission
- Promising Survival with Concomitant Radiochemotherapy with Temozolomide followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Multiforme.
- Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin
- Fatal myocardial aspergillosis in an immunosuppressed child
- Does bladder opacification influence dose distribution in prostate cancer three dimensional conformal radiotherapy?
- Total-body irradiation before allogeneic bone marrow transplant: Is more dose, always better?
- Potential role of intensity modulated proton beams in prostate cancer radiotherapy.
- X-ray dose to the skin in patients undergoing percutaneous transluminal coronary angioplasty
- The exchange of radiotherapy data as part of an electronic patient referral system.
- Optimizing radiotherapy of orbital and paraorbital tumors: intensity modulated X-ray beams versus intensity modulated proton beams
- Patient positioning in prostate radiotherapy: is prone better than supine?
- Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small cell lung cancer
- Pediatric medulloblastoma: prognostic value of p53, bcl-2, MIB-1, and microvessel density.
- Altered apoptototic profiles in irradiated patients with increased toxicity
- Prospective pilot study of sildenafil for treatment of post-radiotherapy erectile dysfunction in patients with prostate cancer
- Skin radionecrosis after percutaneous transluminal coronary angioplasty: dosimetric and biological assessments.
- Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme. Report of EORTC trial 22933
- Pediatric medulloblastoma: results of the Swiss Pediatric Oncology Group
- Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes?
- Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma
- The influence of field size and other treatment parameters on acute toxicity in pharyngo-laryngeal cancers
- Combined chemotherapy and radiation therapy for invasive cancer of the bladder: a feasibility approach in a non-selected population
- Alternating radiotherapy and chemotherapy for inoperable stage III non-small cell lung cancer: long-term results of two Phase II GOTHA trials
- Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment
- Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone
- Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas.
- Potential role of proton therapy in the treatment of pediatric medulloblastoma/peripheral neuro-ectodermal tumors: spinal theca irradiation.
- Potential role of proton therapy in the treatment of pediatric medulloblastoma/peripheral neuro-ectodermal tumors: reduction of the supratentorial target volume
- Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinomas.
- Effect of arytenoid sparing during radiation therapy of early stage glottic carcinoma.
- Pediatric medulloblastoma: radiation treatment technique and patterns of failure
- Influence of transurethral resection on sexual dysfunction in patients with prostate cancer
- Reproducibilty of conformal radiation therapy in localized carcinoma of the prostate without rigid immobilization
- Renal toxicity after allogeneic bone marrow transplant: the combined effects of total body irradiation and graft versus host disease.
- Nausea and vomiting in fractionated radiotherapy: from surveillance to Tropisetron rescue for non responders to Metoclopramide
- Case Report: Kaposi's sarcoma following allogeneic bone marrow transplantation.
- Can a total body irradiation technique be fast and reproducible?
- Chemo-radiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison
- Prognosis of human chorionic gonadotropin-producing seminoma treated by post-operative radiotherapy.
- Radiotherapy for supratentorial low-grade gliomas: Results and prognostic factors with special focus on tumor volume parameters.
- Conditioning the leukemic patient before allogeneic bone marrow transplant: The value of intensifiyng immunosuppression in the context of different levels of graft T-lymphocyte depletion.
- Potential improvement of three-dimension treatment planning and proton beams inthe treatment of large cerebral arteriovenous malformations.
- The role of radiotherapy in the treatment of subtotally resected benign meningiomas
- Radiation therapy and breast conservation: cosmetic results and complications.
- Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer.
- Metastatic ependymoma of the sacrum.
- Fractionation sensitivity and immunological statut in radiation treated murine sarcomas
- Increased Efficacy of Radiation Therapy by Use of Proton Beams
- Fibromatoses: From postsurgical surveillance to combined surgery and radiation therapy.
- Potential impact of improvements in Radiation Therapy on quality of life and survival
- Integration of nutritional care into cancer treatment: need for improvement
- Radioterapia en el cáncer de recto.
- Cancer de la prostate à Genève, 1991-98: Caracteristiques epidemiologiques et tolerance à la radiothérapie des patients traités à visée curative"
- Radioterapia conformacional en el cáncer de vejiga: límites a la precisión y ventajas potenciales del uso de haces de protones.
- The importance of radiotherapy in treatment strategies allowing organ preservation.
- Acquisitions thérapeutiques 1993. Radio-oncologie.
- L'influence de l'évaluation histologique d'une masse cérébrale dans la prise de décision thérapeutique du radio-oncologue.
- Cancer de l'estomac: vers une approche thérapeutique multidisciplinaire?
- Curiethérapie en cancérologie: notions de base et perspectives d'avenir.
- A propos d'un cas de PNET (Primitive neuroectodermal tumor) de la région pinéale chez une jeune femme.
- Benefices du contrôle local dans le traitement du cancer. Role de la Radio-Oncologie.
- Les formes limitées des cancers anaplasiques à petites cellules sont-elles curables?
- Human tumor xenografts as models for study of the radiation response of human tumors.
- Accidentes por radiaciones : principios y bases de actuacion.
- Influence of neonatal thymectomy on IgM and IgG response to sheep erythrocytes in the Swiss white mouse.
- Cancer/Oncology Consultation
- Image Guided Radiotherapy (IGRT)
- Proton Therapy
- Radiology
- Radiotherapy Consultation and Treatment
- Stereo-tactic Radiation Therapy (SRT)
- European Scientific Institute (ESI)
- Centre Européen de Recherche Nucléarie, CERN
- Since June 2020 - member of the International Advisory Board at Kutaisi International University, Georgia to help to implement a National Protontherapy project.
More Information
Education:
- Additional training at the Radiation Therapy Department at the Royal Marsden Hospital in Sutton-Surrey, UK (1983)
- Internship at the Radiation Oncology Department of City of Hope National Medical Center in Duarte-California, US (1985)
- Senior resident and clinical/research fellow at the Radiation Medicine Department, Harvard Cyclotron (1987-1989)
International Fellowships:
- Thesis: "Fibromatoses: D'une surveillance postchirurgicale à l'association de chirurgie et radiothérapie".
- Thesis # 9902. 1997. Academic degree of "Docteur en Médecine" (University of Geneva) - Thesis: "Potential role of proton beam therapy in pediatric brain tumors", 1996. Academic degree of "Privat Docent" (University of Geneva)
Reviewer for the following peer-reviewed journals: Acta Neurochir, Acta Oncologica, Annals of Oncology, Bone Marrow Transpl, Brachytherapy, British Journal of Cancer, Cancer Detection Prevention, Cancer Investigation, Clinical Ophtalmology, Clinical Cancer Research, Critical Rew Oncol/Hematol, Frontiers in Oncology, Future Oncology, Int J Nanomedicine, Int J Radiat Oncol Biol Phys, Neurol India, Oncology, Radiation Oncology, Open Access Surgery, Radiation Research, Radiother Oncol, Technol Cancer Research Treat, The Lancet Oncology, The Oncologist.